Report - DELIVERING NEXT-GENERATION RADIO-IMMUNOTHERAPIES … · 85% - B-cell NHL 7th most common cancer 15% - T-cell NHL in the US1 • Treatment dominated by anti -CD20 immunotherapy (RTX)

Please pass captcha verification before submit form